Global Botulism Market: Introduction
- Botulism (or botulism poisoning) is an uncommon, yet intense disease that transmits through food, contact with tainted soil, or through an open injury. Without early treatment, botulism can lead to paralysis, breathing challenges, and death.
- Botulism poisoning is caused due to a toxin produced by a kind of bacteria known as Clostridium botulinum. These bacteria can flourish in conditions deprived of oxygen. For instance, certain food sources such as preserved or fermented food and homemade canned food are potent breeding ground for bacteria.
- Botulinum toxins are one of the deadliest substances known. This toxin blocks the functionality of nervous system, which can lead to respiratory and muscular paralysis.
- Different types of botulism are:
- Infant botulism
- Foodborne botulism
- Wound botulism
- Inhalation botulism
- Other types
Key Drivers and Restraint of Global Botulism Market
- Technological advancements in the health care industry have led to introduction of various types of antitoxin and antibiotics for the treatment of botulism. Large number of research & development initiatives and availability of new solutions are projected to be the key drivers of the global botulism market during the forecast period.
- According to the Centers for Disease Control and Prevention (CDC), in 2017, 182 confirmed cases of botulism were reported in the U. S., out of which 141 (77%) were infant botulism, 19 (10%) were foodborne botulism, 19 (10%) were wound botulism, and 3 (1%) were other types. Increase in incidence rate of botulism is anticipated to drive the global botulism market.
- However, significant investment required for development of botulism treatments and late & incorrect diagnosis of the disease are expected to restrain the global botulism market
- Inadequate knowledge and awareness about botulism, lack of proper health care infrastructure in emerging regions, and unaffordability in middle-income countries are the other restraints of the global botulism market
North America to Lead Global Botulism Market
- In terms of region, the global botulism market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America was the largest market in 2019 due to rise in prevalence of clostridium botulinum diseases in the region. According to the CDC, on average 145 cases of botulism are recorded in the U.S. every year. Of these, around 15% are foodborne botulism, 65% are infant botulism, and 20% are wound botulism.
- Europe is projected to account for significant share of the global botulism market during the forecast period. This is attributed to rise in awareness about various bacteria such as Clostridium botulinum and stringent government guidelines to ensure better security of individuals in the region. For example, in January 2019, Grupo Dia called back a batch of canned sardines in olive oil from Spain and Portugal due to risk of botulinum toxin that can cause botulism.
- The botulism market in Asia Pacific is anticipated to grow at the fastest pace during the forecast period because of the expanding patient pool, increase in awareness about health, government initiatives to improve health care infrastructure, and availability of modern treatment techniques. Moreover, rise in prevalence of communicable diseases drives the botulism market in Asia Pacific.
- The market in Latin America and Middle East & Africa is expected to witness sluggish growth during the forecast period due to lack of awareness and restricted access and availability of treatment facilities
- In the Middle East, the United Arab Emirates and Saudi Arabia are the largest markets owing to advancements in the health care industry and increase in availability of specialty care centers
Key Players Operating in Global Botulism Market
- Alphavax, Inc.
- Ology Bioservices
- Morphotek, Inc.
- Bausch Health Companies, Inc.
- Medytox
- Molecular Targeting Technologies, Inc.
- Lanzhou Institute of Biological Products Co., Ltd.
- Metabiologics, Inc.
- Merz Pharma
- Galderma SA
- Revance Therapeutics, Inc.
- Emergent BioSolutions, Inc.
Global Botulism Market: Research Scope
Global Botulism Market, by Type
- Foodborne botulism
- Infant botulism
- Wound botulism
- Inhalation botulism
- Other types
Global Botulism Market, by Treatment Type
- Antitoxin
- Antibiotics
- Others
Global Botulism Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Stores
- Others
Global Botulism Market, by Region
- North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Interested in this report?
Get a FREE Brochure now!
